Shree Ganesh Remedies Ltd. (SGRL): Shree Ganesh Remedies Share Price rises 17.45% to Rs 640.10

Published: 31 August 2026 at 9:19:50 AM IST

Shree Ganesh Remedies Share Price rose sharply today, with the stock closing at Rs 640.10 after a gain of 17.45% from the previous close of Rs 545.00. The move added Rs 95.10 to the share price and lifted the company’s market capitalisation to Rs 699.65 crore. In Stock Market Today terms, this is a notable price rise for SGRL, and it places Shree Ganesh Remedies Share Price news firmly on the radar of market participants tracking Stocks in News and Top Gainers Today.

The session opened at Rs 642.00, touched an intraday high of Rs 654.00 and a low of Rs 615.00, while turnover stood at Rs 0.57 crore. The supplied data confirms the day’s price event, but it does not establish a company-specific catalyst. For readers tracking Shree Ganesh Remedies Share Price Today, the important question is not only what moved the stock, but also how the current valuation and healthcare-sector comparisons frame the move.

In this Univest note, the focus is on verified facts only: today’s price action, the valuation profile, the sector benchmark, and how Shree Ganesh Remedies Share Price fits within the Pharmaceuticals & Drugs industry. That makes this both a Shree Ganesh Remedies Stock News update and a practical stock analysis snapshot for Indian Stock Market readers.

Shree Ganesh Remedies Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 640.1
Previous Close	Rs 545
Today's Move	Rs 95.1 (+17.45%)
Open	Rs 642
High	Rs 654
Low	Rs 615
Turnover	Rs 0.57 crore
Market Capitalisation	Rs 699.65 crore
Market Cap Category	Micro Cap

Shree Ganesh Remedies Ltd. (SGRL) rose to Rs 640.1 from the previous close of Rs 545, a move of Rs 95.1 or 17.45%. The stock opened at Rs 642, reached a high of Rs 654, recorded a low of Rs 615.

Shree Ganesh Remedies Share Price today moved from Rs 545.00 at the previous close to Rs 640.10, a day gain of Rs 95.10 or 17.45%. The stock opened at Rs 642.00, traded between Rs 615.00 and Rs 654.00 during the session, and ended near the upper part of that day’s range. Turnover was Rs 0.57 crore, which is a factual traded-value measure and should be read together with the price move rather than as a signal of participation or conviction. For investors following Shree Ganesh Remedies Share Price Live updates, the day’s range and closing level are the main facts to note.

This kind of price rise makes Shree Ganesh Remedies Share Price a notable mover in today’s Share Market Today coverage. The data shows a clear one-day gain, but it does not by itself explain why the stock is rising today. That distinction matters for Shree Ganesh Remedies Share Price Update readers who want a clean separation between observed price action and any unverified story around it.

At a current price of Rs 640.10, Shree Ganesh Remedies Share Price is also trading with a market capitalisation of Rs 699.65 crore. That places the move in the context of a company whose valuation and peer comparison can be checked directly through the supplied financials, rather than through assumptions about market sentiment. Univest uses that same factual approach across Stock Updates and Market Movers coverage.

Shree Ganesh Remedies Ltd. (SGRL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 699.65 crore
P/E Ratio	45.33x
P/B Ratio	4.26x
ROE	11.53%
ROCE	14.63%
EPS	Rs 12.02
Book Value Per Share	Rs 127.82
Dividend Yield	0%

Shree Ganesh Remedies Ltd. (SGRL) fundamental metrics show P/E 45.33x, P/B 4.26x, ROE 11.53%, ROCE 14.63%. These figures provide context only and are not a buy or sell signal.

Shree Ganesh Remedies Ltd. has a market capitalisation of Rs 699.65 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 45.33x, P/B at 4.26x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.53% and ROCE of 14.63%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 12.02, book value per share of Rs 127.82, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.21x, median ROE of 11.78%, median ROCE of 13.6%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	45.33x
Benchmark Median P/E	31.21x
Benchmark Average P/E	48.1x
Benchmark P/E Range	3.7x to 672.45x
Company P/B Ratio	4.26x
Benchmark Median P/B	2.88x
Company ROE	11.53%
Benchmark Median ROE	11.78%
Company ROCE	14.63%
Benchmark Median ROCE	13.6%
Company Market Capitalisation	Rs 699.65 crore
Benchmark Median Market Cap	Rs 670.73 crore

Shree Ganesh Remedies Ltd. (SGRL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Shree Ganesh Remedies Ltd. (SGRL) has a P/E ratio of 45.33x, which is above the benchmark median of 31.21x, a difference of +45.24%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Shree Ganesh Remedies Ltd. (SGRL) has a ROE of 11.53%, which is below the benchmark median of 11.78%, a difference of -2.12%. Shree Ganesh Remedies Ltd. (SGRL) has a ROCE of 14.63%, which is above the benchmark median of 13.6%, a difference of +7.57%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,60,696.31	38.09	5.33	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,46,062.83	84.12	13.93	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,91,515.22	87.81	21.34	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,18,403.7	26.24	4.39	19.69	21.39
Cipla Ltd.	CIPLA	1,14,554.33	33.99	3.26	11.83	16

Shree Ganesh Remedies Ltd. (SGRL) has a P/E ratio of 45.33x compared with the displayed peer median of 38.09x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.53% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 14.63% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Shree Ganesh Remedies Ltd. (SGRL) has a market capitalisation of Rs 699.65 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Shree Ganesh Remedies

• Shree Ganesh Remedies Share Price rose 17.45% today to Rs 640.10, moving Rs 95.10 above the previous close of Rs 545.00.
• The stock’s market capitalisation now stands at Rs 699.65 crore, which is slightly above the same-industry median of Rs 670.73 crore.
• The P/E ratio is 45.33 and the P/B ratio is 4.26, both relevant to Shree Ganesh Remedies Stock Analysis and valuation checks.
• ROE is 11.53% and ROCE is 14.63%, so the company’s return profile can be compared directly with sector medians.
• The move sits within the Healthcare sector and Pharmaceuticals & Drugs industry, where Shree Ganesh Remedies Share Price can be compared with listed peers.

About Shree Ganesh Remedies

Shree Ganesh Remedies Ltd. is a listed company in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies the business category, but not a detailed segment breakdown, so this note stays with the verified company context. For investors reading Shree Ganesh Remedies Company News, that means the most reliable starting point is the company’s market position, valuation ratios and industry classification.

Within this frame, Shree Ganesh Remedies Share Price is best understood as a stock from a specialised pharmaceutical universe rather than as a broad-market name. Its market capitalisation of Rs 699.65 crore and book value of Rs 127.82 provide a factual basis for analysis, while EPS of Rs 12.02 and ROCE of 14.63% add further operating context. Univest keeps the company overview factual so readers can align Shree Ganesh Remedies Latest News with the actual numbers first.

Track Shree Ganesh Remedies Share Price on Univest

Use Shree Ganesh Remedies Ltd. (SGRL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Shree Ganesh Remedies Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps users review Shree Ganesh Remedies Share Price Today alongside valuation metrics, sector context and peer comparisons in one place.

For users following Shree Ganesh Remedies Stock News, Univest provides a practical way to monitor the stock’s share price update, company news and earnings context without relying on scattered market pages. It is a straightforward tracking hub for factual market information.

Frequently Asked Questions

Why is Shree Ganesh Remedies Share Price rising today?

Ans. The stock rose 17.45% to Rs 640.10, but the supplied data does not establish a company-specific catalyst. The verified facts confirm the price rise, intraday range and turnover, not the reason behind the move.

What is Shree Ganesh Remedies Share Price today?

Ans. Shree Ganesh Remedies Share Price today is Rs 640.10. It gained Rs 95.10 from the previous close of Rs 545.00 and traded between Rs 615.00 and Rs 654.00 during the session.

What is the market capitalisation of Shree Ganesh Remedies?

Ans. The company’s market capitalisation is Rs 699.65 crore. That places it slightly above the same-industry median market cap of Rs 670.73 crore, while still far below several large healthcare peers.

What do Shree Ganesh Remedies valuation ratios show?

Ans. The stock has a P/E of 45.33 and a P/B of 4.26. Compared with the same-industry medians, the valuation sits above the P/E and P/B median levels in the supplied benchmark.

How do ROE and ROCE compare for Shree Ganesh Remedies?

Ans. ROE is 11.53% and ROCE is 14.63%. ROE is near the industry median of 11.78%, while ROCE is above the benchmark median of 13.60%, giving useful profitability context. ROE stands at 11.53%.

How does Shree Ganesh Remedies compare with peers?

Ans. Its market cap is much smaller than Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals. On valuation, its P/E is above Zydus Lifesciences and Sun Pharma, but below Divi’s and Torrent.

What is the EPS and book value of Shree Ganesh Remedies?

Ans. EPS is Rs 12.02 and book value is Rs 127.82. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share at the current stage.

Should investors track Shree Ganesh Remedies Share Price on Univest?

Ans. Univest lets users track Shree Ganesh Remedies Share Price with live updates, ratios, shareholding pattern and sector comparisons. It is a useful place to follow factual market data and company context together.